{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:39:56Z","timestamp":1779341996519,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[1997,10,1]],"date-time":"1997-10-01T00:00:00Z","timestamp":875664000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1997,10]]},"DOI":"10.1007\/bf01273324","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T02:56:44Z","timestamp":1111633004000},"page":"1113-1123","source":"Crossref","is-referenced-by-count":69,"title":["Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism"],"prefix":"10.1007","volume":"104","author":[{"given":"R.","family":"Maggio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Riva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Vaglini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Fornai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Racagni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. U.","family":"Corsini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0006-8993(91)90958-X","volume":"551","author":"E Aizenman","year":"1991","unstructured":"Aizenman E, Lian-Hong T, Reynolds IJ (1991) Effects of nicotinic agonists on the NMDA receptor. Brain Res 551: 355?357","journal-title":"Brain Res"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0169-328X(93)90088-7","volume":"17","author":"T Asai","year":"1993","unstructured":"Asai T, Wanaka A, Kato H, Masana Y, Seo M, Tohyama M (1993) Differential expression of two members of FGF receptor gene family, FGFR-1 and FGFR-2 mRNA, in the adult rat central nervous system. Mol Brain Res 17: 174?178","journal-title":"Mol Brain Res"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1212\/WNL.36.11.1490","volume":"36","author":"JA Baron","year":"1986","unstructured":"Baron JA (1986) Cigarette smoking and Parkinson's disease. Neurology 36: 1490?1495","journal-title":"Neurology"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"10237","DOI":"10.1073\/pnas.88.22.10237","volume":"88","author":"AJ Bean","year":"1991","unstructured":"Bean AJ, Elde R, Cao Y, Oellig C, Tamminga C, Goldstein M, Pettersson RF, Hoxfelt T (1991) Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey and human. Proc Natl Acad Sci USA 88: 10237?10241","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","volume":"80","author":"RS Burns","year":"1983","unstructured":"Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80: 4546?4550","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00001756-199110000-00011","volume":"2","author":"A Cintra","year":"1991","unstructured":"Cintra A, Cao Y, Oellig C, Tinner B, Bortolotti R, Pettersson RF, Fuxe K (1991) Basic FGF is present in dopaminergic neurons of the ventral midbrain of the rat. NeuroReport 2: 597?600","journal-title":"NeuroReport"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/10409239409086798","volume":"29","author":"BM Conti-Tronconi","year":"1994","unstructured":"Conti-Tronconi BM, McLane KE, Raftery MA, Grando SA, Protti MP (1994) The nicotinic acetylcholine receptor: structure and autoimmune pathology. Crit Rev Biochem Mol Biol 29: 69?123","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0014-2999(85)90331-0","volume":"119","author":"GU Corsini","year":"1985","unstructured":"Corsini GU, Pintus S, Chiueh CC, Weiss JF, Kopin IJ (1985) 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate. Eur J Pharmacol 119: 127?128","journal-title":"Eur J Pharmacol"},{"key":"CR9","first-page":"167","volume":"69","author":"F Fornai","year":"1996","unstructured":"Fornai F, Vaglini F, Maggio R, Bonuccelli U, Corsini GU (1996) Excitatory amino acids and MPTP toxicity. Adv Neurol 69: 167?176","journal-title":"Adv Neurol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/379733a0","volume":"379","author":"JS Fowler","year":"1996","unstructured":"Fowler JS, Volkow ND, Wang G-J, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cliento R (1996) Inhibition of monoamine oxidase B in the brains of smokers. Nature 379: 733?736","journal-title":"Nature"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/neu.480251109","volume":"25","author":"FJ Hefti","year":"1994","unstructured":"Hefti FJ (1994) Neurotrophic factor therapy for nervous system degenerative diseases. Neurobiology 25: 1418?1435","journal-title":"Neurobiology"},{"key":"CR12","first-page":"257","volume":"214","author":"AJ Hotchkiss","year":"1980","unstructured":"Hotchkiss AJ, Gibb JW (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J Pharmacol Exp Ther 214: 257?262","journal-title":"J Pharmacol Exp Ther"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0163-7258(94)90041-8","volume":"64","author":"DM Jackson","year":"1994","unstructured":"Jackson DM, Westind-Danielsson A (1994) Pharmacol Ther 64: 291?369","journal-title":"Pharmacol Ther"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard PA, Tetrud JW, Irwin I (1983) Chronic parkinsonism in human due to a product of meperidine-analog synthesis. Science 219: 979?980","journal-title":"Science"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1136\/bmj.311.7020.1602","volume":"311","author":"AJ Lees","year":"1995","unstructured":"Lees AJ on behalf of the Parkinson's Disease Research Group of the United Kingdom (1995) Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Br Med J 311: 1602?1607","journal-title":"Br Med J"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1097\/00001756-199410000-00035","volume":"5","author":"P Marin","year":"1994","unstructured":"Marin P, Maus M, Desagher S, Glowinski J, Pr\u00e9mont J (1994) Nicotine protects cultured striatal neurons against N-methyl-D-aspartate receptor-mediated neurotoxicity. NeuroReport 5: 1977?1980","journal-title":"NeuroReport"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0304-3940(92)90797-B","volume":"148","author":"EG McGeer","year":"1992","unstructured":"McGeer EG, Singh EA, McGeer PL (1992) Apparent anterograde transport of basic fibroblast growth factor in the rat nigrostriatal dopamine system. Neurosci Lett 148: 31?33","journal-title":"Neurosci Lett"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.45.6.1041","volume":"45","author":"DM Morens","year":"1995","unstructured":"Morens DM, Grandinetti A, Reed D, White LR, Ross GW (1995) Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue? Neurology 45: 1041?1051","journal-title":"Neurology"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0304-3940(92)90642-K","volume":"136","author":"A Muraki","year":"1992","unstructured":"Muraki A, Koyama T, Nakayama M, Ohmori T, Yamashita I (1992) MK-801, a non-competitive antagonist of NMDA receptor prevents methamphetamine-induced decrease of striatal dopamine uptake sites in the rat striatum. Neurosci Lett 136: 39?42","journal-title":"Neurosci Lett"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1523\/JNEUROSCI.10-06-01912.1990","volume":"10","author":"D Otto","year":"1990","unstructured":"Otto D, Unsicker K (1990) Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J Neurosci 10: 1912?1921","journal-title":"J Neurosci"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1056\/NEJM198911163212004","volume":"321","author":"Parkinson's Study Group","year":"1989","unstructured":"Parkinson's Study Group (1989) Effects of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 321: 1364?1371","journal-title":"N Engl J Med"},{"key":"CR22","unstructured":"Sidman RL, Angevine Jr JB, Taber Pierce E (1971) Atlas of the mouse brain and spinal cord. Harvard University Press"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1126\/science.2563176","volume":"243","author":"PK Sonsalla","year":"1989","unstructured":"Sonsalla PK, Nicklas WJ, Heikkila RE (1989) Role for excitatory amino acids in methamphetamine induced nigrostriatal dopaminergic toxicity. Science 243: 398?400","journal-title":"Science"},{"key":"CR24","first-page":"506","volume":"256","author":"PK Sonsalla","year":"1991","unstructured":"Sonsalla PK, Riordan DE, Heikkila RE (1991) Competitive and noncompetitive antagonist at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J Pharmacol Exp Ther 256: 506?512","journal-title":"J Pharmacol Exp Ther"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1126\/science.2502843","volume":"245","author":"JW Tetrud","year":"1989","unstructured":"Tetrud JW, Langston JW (1989) The effect of deprenyl (selegiline) on the natural history of Parkinson's disease. Science 245: 519?522","journal-title":"Science"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1212\/WNL.43.2.372","volume":"43","author":"I Tooyama","year":"1993","unstructured":"Tooyama I, Kawamata T, Walker D, Yamada T, Hanai K, Kimura H, Iwane M, Igarashi K, McGeer EG, McGeer PL (1993) High molecular weight basic fibroblast growth factor-like protein is localized to a subpopulation of mesencephalic dopaminergic neurons in the rat brain. Neurology 43: 372?376","journal-title":"Neurology"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0006-8993(94)90524-X","volume":"668","author":"F Vaglini","year":"1994","unstructured":"Vaglini F, Fascetti F, Fornai F, Maggio R, Corsini GU (1994) (+)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice. Brain Res 668: 194?203","journal-title":"Brain Res"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0006-8993(94)01457-S","volume":"674","author":"F Vaglini","year":"1995","unstructured":"Vaglini F, Pardini C, Cavalletti M, Maggio R, Corsini GU (1995) L-Deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion. Brain Res 674: 127?132","journal-title":"Brain Res"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-8993(80)91265-2","volume":"171","author":"GC Wagner","year":"1980","unstructured":"Wagner GC, Ricarute GA, Seiden LS, Schuster CR, Miller JM, Westly J (1980) Long-lasting depletion of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 171: 151?160","journal-title":"Brain Res"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0896-6273(90)90164-B","volume":"5","author":"A Wanaka","year":"1990","unstructured":"Wanaka A, Johnson EM, Milbrandt J (1990) Localization of FGF receptor mRNA in the adult rat central nervous system by in situ hybridization. Neuron 5: 267?281","journal-title":"Neuron"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01273324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01273324\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01273324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T14:14:40Z","timestamp":1556633680000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01273324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["BF01273324"],"URL":"https:\/\/doi.org\/10.1007\/bf01273324","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,10]]}}}